Abstract:Aspiration pneumonia (AP) is a commonly utilized term, but one that is often overlooked, yet also overdiagnosed. Although aspiration is part of the pathogenesis of most episodes of pneumonia, the term AP refers to gross aspiration of gastric or oropharyngeal contents into the lower airway and lung. AP can be present in up to 20% of patients with community-acquired pneumonia (CAP) and an unknown percentage of cases of hospital-acquired pneumonia (HAP). CAP patients with AP have a worse prognosis compared with those with non-AP. Aspiration can lead to both infectious or noninfectious pneumonitis, depending on the bacterial burden of gastric and oropharyngeal contents, and the composition of the inhaled material (bacterial contamination, inert substances such as blood, or gastric contents with a low pH). The term chemical pneumonitis refers to the aspiration of noncolonized gastric content (usually with a low pH) to the lower airways that can often lead to inflammation and lung injury, yet resolve without antibiotics. In this issue of SRCCM, we are privileged to have comprehensive reviews by subject experts, on several important aspects of AP. The epidemiology of AP is covered by Almirall and colleagues, confirming the large burden of AP in CAP and HAP and the worse outcomes compared with non-APs. The bacteriology of AP is now better understood after bronchoscopic studies and an appreciation of the role of the respiratory microbiome in pathogenesis. "Core" pathogens in CAP such as Streptococcus pneumoniae , Haemophilus influenzae , and Staphylococcus aureus are the main organisms involved with AP, but Gram-negative bacilli, including nonfermenters, have also played an important role, based on bronchoscopic studies. Most importantly, these studies have shown the relatively low frequency of anaerobic infection, contrary to prior concepts. Anaerobes are not common in most patients with AP, except in those with aspiration leading to pulmonary abscess or empyema. Fadell and colleagues have expertly reviewed these issues. The role of bronchoscopy is often debated, and Darie and Stolz argue that this procedure should be performed more often in patients with AP. Bronchoscopy can facilitate examination of the upper and lower airways and identify inflammation and the presence of a foreign body. In addition, it can allow sampling of distal respiratory secretions for microbiological processing. It also allows for the measurement of biomarkers like amylase, which can help to confirm the diagnosis of AP. One of the main causes of AP is swallowing disorders that are extremely frequent in the elderly, and numerous methods have been proposed to diagnose and to treat problems, with the possibility of using artificial intelligence methodology in the future. We now better understand the mechanics of swallowing and how it can become abnormal. Ortega and colleagues have reviewed in depth the pathophysiology mechanisms, diagnosis, treatment, and prevention of these disorders. Prevention is of particular interest to avoid recurrent episodes and focuses on nutritional support, altered feeding textures, oral hygiene, positional manipulation during swallowing, and swallowing training. Imaging studies are important in AP, particularly chest computed tomography scanning. On one hand, the location of the infiltrates helps to suspect AP, on the other hand, complications such as necrotizing pneumonia and pulmonary abscess need to be ruled out when the clinical evolution of the patient is slow. Argawala and colleagues discuss this topic, with outstanding visual examples of the principles they discuss. Many medications increase the risk of aspiration and or damage the esophagus. Elderly patients very frequently take polypharmacy, and medications that lead to sedation or alter gastric content and motility can impact aspiration risk. In contrast, some medications (like angiotensin-converting enzyme inhibitors) can promote cough and decrease the risk of aspiration, although the evidence is not strong. Gonçales-Pereira and colleagues discuss this important subject. In the hospital, there are many interventions that increase the risk of AP such as anesthesia, intubation and mechanical ventilation, enteral feeding, and invasive procedures. Osorio and colleagues and Battaglini and colleagues summarize and review the common clinical risk factors. Prevention is key in AP, both outside and inside the hospital. Patients who present a first episode of AP are prone to have a second one or more. Since AP is a complex and multifactorial process, prevention protocols are not simple and have to include measures such as body position, nutritional aspects, and dental hygiene, with other strategies being developed. Perticone and colleagues dedicate a chapter to the prevention of AP. AP needs to be treated with antibiotics, when it is of bacterial o -Abstract Truncated-

Therapy of Aspiration: Out-of-Hospital and In-Hospital-Acquired

Is There a Role for Bronchoscopy in Aspiration Pneumonia?

Epidemiology and Pathogenesis of Aspiration Pneumonia

Bacteriology of Aspiration Pneumonia: The Lung Microbiome and the Changing Microbial Etiology

Aspiration Pneumonia: Preface

Prevention of Aspiration: Oral Care, Antibiotics, Others

Aspiration pneumonia and pneumonitis: a spectrum of infectious/noninfectious diseases affecting the lung

Microbiological Profile of Patients with Aspiration Pneumonia Identified by Combined Detection Methods

Aspiration after Anesthesia: Chemical versus Bacterial, Differential Diagnosis, Management, and Prevention

Identifying Risk Factors for Aspiration in Patients Hospitalized with Community-Acquired Pneumonia

Impaired oral health: a required companion of bacterial aspiration pneumonia

Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia

Dynamics of microbiota during mechanical ventilation in aspiration pneumonia

Current Concepts in Community and Ventilator Associated Lower Respiratory Tract Infections in ICU Patients

[Diagnosis and therapy of abscess forming pneumonia]

Medications to Modify Aspiration Risk: Those That Add to Risk and Those That May Reduce Risk

Ethical Issues and the Role of Palliative Care for Patients with Aspiration Pneumonia

[Bacterial resistance and antimicrobial therapy in respiratory medicine and intensive care]

Microbiology of Severe Community-Acquired Pneumonia and the Role of Rapid Molecular Techniques

Severe Community-Acquired Pneumonia in Immunocompromised Patients

High Prevalence of Multidrug-Resistant Nonfermenters in Hospital-Acquired Pneumonia in Asia